In the News and Information section you will find the last news about ReachCentrum, including information on our new services and press releases.
Consortia for Biocidal Products Containing Certain Active Substances.
Brussels, October 23, 2019 - ERM and ReachCentrum are collecting interest in the setting up of consortia. These consortia will facilitate cooperation between producers, distributors and formulators wishing to authorise biocidal products on the EU market according to the rules and procedures required by the Biocidal Products Regulation (EU 528/2012 –the ‘BPR’).
ReachCentrum is the chemical industry recognised expert in the delivery of consortium management services. ERM is a leading global provider of environmental, health, safety, regulatory and sustainability related services, with many years of biocide experience helping companies approve active substances and biocidal products in a wide range of chemistries and product types. Together, they have experts in all disciplines with skills to provide scientific and regulatory knowledge to help gain the required authorisations.
From launching this call of interest to final product authorisation, ERM and ReachCentrum will coordinate all aspects of the proposed consortia and provide the technical and regulatory support necessary to ensure consortia members achieve their goals.
ERM and ReachCentrum are planning to launch consortia to support biocidal products containing the following active substances, within the listed Product Types. Biocidal Product Committee decisions to approve these active substances are likely during 2020 meaning that deadlines to submit applications for product authorisation in EU Member States will likely occur during 2022.
In case you would be interested in joining one of these biocidal product consortia, we kindly ask you to express your interest by 31st December 2019.
|Active Substance||CAS n°||Product Type|
|Active chlorine released from sodium hypochlorite||7681-52-9||11, 12|
|Benzalkonium chloride (BKC)||68424-85-1||1, 2, 3, 4|
|Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents||89997-63-7||18|
|Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide||89997-63-7||18|
|Didecyldimethylammonium chloride (DDAC)||7173-51-5||1, 2, 3, 4|
|Hydrogen peroxide||7722-84-1||11, 12|
|Sodium Chloride (NaCl)||7647-14-5||11|
|Symclosene||87-90-1||2, 3, 4, 5, 11|
|Troclosene sodium (NaDCC)||2893-78-9||2, 3, 4, 5, 11|
|Peroxyoctanoic acid||33734-57-5||2, 3, 4|
To discuss your regulatory support requirements, please contact:
Dr Richard Elsmore, Partner & Global Biocide Lead at [email protected]
Dr Sam Wright, Regulatory Affairs Lead at [email protected]
Dr Cecile Rousseau, Partnerat [email protected]
Andrew Goodyear, Partner at [email protected]
Magdalena Urbanowska, Partner (ReachCentrum) at [email protected]Read more
Following April 16th announcement on ReachCentrum’s upcoming acquisition by ERM, ReachCentrum would like to clarify its position regarding the services it provides related to the EU Biocidal Product Regulation.
ReachCentrum shall honour the Agreements it has with its clients and undertakes to perform cost-effective and high quality services within this sector. We are confident that our well established expertise regarding consortia management and our result-driven approach are guarantees of our high-level engagement and quality management.Read more